Liraglutide in Adults With Obesity: A Multicentre, Single‐Arm, Post‐Marketing Surveillance Study in Taiwan
Shih‐Te Tu, Chiao‐Fan Chiu, Chu‐Kuang Chou, Hai‐Hua Chuang, Shu‐Wei Hu, Wen‐Ching Ko, Chun‐Ying Lee, Wen‐Yuan Lin, Yen‐Jen Sung, Thing‐Fong Tzeng, Weu Wang, Hsiang‐Fan Wu, Chun‐Yan Yeung, Bill Chen, Chet Joe Sim, Kuo‐Chin Huang · 2026
Read Liraglutide in Adults With Obesity: A Multicentre, Single‐Arm, Post‐Marketing Surveillance Study in Taiwan by Shih‐Te Tu, Chiao‐Fan Chiu, Chu‐Kuang Chou, Hai‐Hua Chuang, Shu‐Wei Hu, Wen‐Ching Ko, Chun‐Ying Lee, Wen‐Yuan Lin, Yen‐Jen Sung, Thing‐Fong Tzeng, Weu Wang, Hsiang‐Fan Wu, Chun‐Yan Yeung, Bill Chen, Chet Joe Sim, Kuo‐Chin Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13589615.txt.
Description
Taiwanese regulators wanted real-world evidence on a daily weight-loss injection after it reached the market. Shih-Te Tu and co-authors tracked 259 adults with obesity at fourteen clinics for half a year. The drug, liraglutide, mimics a gut hormone that curbs appetite. Most patients stayed below the full dose, largely because of cost.
Side effects touched about one in nine patients and were mostly mild stomach or injection-site complaints. Weight fell steadily anyway: about six kilograms by three months and eight and a half by six. Three quarters of patients lost at least five percent of their weight. Blood pressure improved too. The authors flag drug cost as the main barrier to long-term treatment.
Catalog record
| CREATOR | Shih‐Te Tu, Chiao‐Fan Chiu, Chu‐Kuang Chou, Hai‐Hua Chuang, Shu‐Wei Hu, Wen‐Ching Ko, Chun‐Ying Lee, Wen‐Yuan Lin, Yen‐Jen Sung, Thing‐Fong Tzeng, Weu Wang, Hsiang‐Fan Wu, Chun‐Yan Yeung, Bill Chen, Chet Joe Sim, Kuo‐Chin Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |